8:41AM ET 7/01/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
5:36AM ET 6/15/2022 MT NewswiresPacira BioSciences (PCRX) has an average rating of outperform and price targets ranging from $54 to $94, according to analysts polled by Capital IQ. (MT...
7:11AM ET 6/09/2022 MT NewswiresDavid M Stack, Director, Chief Executive Officer and Chairman, on June 06, 2022, sold 25,793 shares in Pacira Biosciences (PCRX) for $1,561,998. Following...
7:06AM ET 6/09/2022 MT NewswiresRoy Winston, Chief Medical Officer, on June 06, 2022, sold 17,546 shares in Pacira Biosciences (PCRX) for $1,077,135. Following the Form 4 filing with the...